Exane Derivatives’s Cidara Therapeutics CDTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,336	Closed	-$93.4K	–	912
2020 Q4	$93.4K	Buy	2,336 +543	+30%	+$21.7K	0.03%	396
2020 Q3	$102K	Sell	1,793 -118	-6%	-$6.73K	0.03%	278
2020 Q2	$141K	Hold	1,911	–	–	0.04%	226
2020 Q1	$94.8K	Buy	+1,911	New	+$94.8K	0.03%	268